Aurobindo Pharma hits record ₹1,856 as pharma index climbs

Aurobindo Pharma hit a record ₹1,856 on 9 November 2026 as Nifty Pharma touched a 52-week high, with the 20-day average near ₹1,680. Aurobindo Pharma Limited [ AUROPHARMA] hit a fresh all-time high of ₹1,856 on 9 November 2026 and closed at ₹1,855.30, up 2.84%. It was the 12th straight positive close. Two things drove the move. The company reported Q2FY27 results on 4 November, with net profit up 32.5% to ₹1,124 crore and record revenue. The sector also turned strong. Nifty Pharma hit a fresh 52-week high at midday, up about 1.4%, as several drugmakers reported September-quarter earnings. The index is up 27% in 2026. On the daily chart, the stock pulled back to about ₹1,550 in October, then reclaimed its 20-day average and cleared the earlier peak near ₹1,740. The trend is strongly bullish and momentum is strongly positive. Prices are in untouched territory, so there is no overhead resistance from past highs. The 20-day SMA, near ₹1,680, may act as support. It sits about 9% below the close, so a pullback to it would be sizeable. A close under it would weaken the setup. After a 12-day run, a pause would be normal. Watch for follow-through above ₹1,856 and whether the pharma index holds its new high. Stance: bullish while the stock holds above ₹1,680. Disclosure: I do not hold any position in this stock. This is not a recommendation to buy or sell. Investments in securities markets are subject to market risks. Read all related documents carefully before investing.